Clinical trials for Acute leukemia of ambiguous lineage
12 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07046078Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid CancerFred Hutchinson Cancer Center · PI: Filippo Milano, MD, PhD
- RECRUITINGPhase 2NCT06317662Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaNational Cancer Institute (NCI) · PI: Erin H Breese
- RECRUITINGPhase 2NCT06013423Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic DiseasesFred Hutchinson Cancer Center · PI: Ann Dahlberg
- ACTIVE NOT RECRUITINGPhase 2NCT05761171A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaChildren's Oncology Group · PI: Kelly E Faulk
- RECRUITINGPhase 2NCT05901974Venetoclax Combined With Azactidine in the Treatment of ALALSheng-Li Xue, MD
- RECRUITINGPhase 2NCT05735717MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesMasonic Cancer Center, University of Minnesota · PI: Margaret MacMillan
- ACTIVE NOT RECRUITINGPhase 1NCT04898894Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaSt. Jude Children's Research Hospital · PI: Seth Karol, MD
- RECRUITINGPhase 2NCT04099966AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell DepletionMitchell Cairo · PI: Mitchell S Cairo
- RECRUITINGPhase 2NCT04440267Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous LineageInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGN/ANCT03810196CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCTChildren's Hospital of Philadelphia · PI: Timothy Olson, MD, PhD
- RECRUITINGPhase 1NCT03826992Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute LeukemiaChildren's Hospital Medical Center, Cincinnati · PI: John Perentesis, MD
- RECRUITINGN/ANCT03050268Familial Investigations of Childhood Cancer PredispositionSt. Jude Children's Research Hospital · PI: Kim E. Nichols, MD